Integrated Telecommunications Services
0 - 0 of 80 companies.
- BRIEF-Corbus Pharma preclinical data demonstrates JBT-101 reduces inflammation in alveolar macrophages
- BRIEF-Mabvax Therapeutics announces FDA authorization to proceed with MVT-1075 in a Phase I clinical trial for the treatment of pancreatic cancer
- BRIEF-Delbrook Capital Advisors-in response to rapier's proposal to proceed with placement, expects to commence legal proceedings due to "oppressive" conduct by Rapier